EcoDrugPlus

Endothelin Converting Enzyme 1

Ensembl ID : ENSDNOG00000043588
Gene Symbol: ECE1
4 Cross references
230 Possible Orthologues:

Endothelin Receptor Type A

Ensembl ID : ENSDNOG00000008464
Gene Symbol: EDNRA
2 Cross references
270 Possible Orthologues:

Endothelin Receptor Type B

Ensembl ID : ENSDNOG00000031575
Gene Symbol: EDNRB
2 Cross references
267 Possible Orthologues:

Enhancer Of Zeste 2 Polycomb Repressive Complex 2 Subunit

Ensembl ID : ENSDNOG00000003130
Gene Symbol: EZH2
2 Cross references
236 Possible Orthologues:

Epidermal Growth Factor Receptor

Ensembl ID : ENSDNOG00000015935
Gene Symbol: EGFR
2 Cross references
287 Possible Orthologues:

Epoxide Hydrolase 2

Ensembl ID : ENSDNOG00000008521
Gene Symbol: EPHX2
2 Cross references
204 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 2

Ensembl ID : ENSDNOG00000015671
Gene Symbol: ERBB2
2 Cross references
200 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 3

Ensembl ID : ENSDNOG00000001011
Gene Symbol: ERBB3
4 Cross references
280 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSDNOG00000008423
Gene Symbol: ERBB4
2 Cross references
320 Possible Orthologues:

Estrogen Receptor 1

Ensembl ID : ENSDNOG00000038208
Gene Symbol: ESR1
4 Cross references
212 Possible Orthologues:

Estrogen Receptor 2

Ensembl ID : ENSDNOG00000013868
Gene Symbol: ESR2
4 Cross references
274 Possible Orthologues:

Estrogen Related Receptor Gamma

Ensembl ID : ENSDNOG00000037798
Gene Symbol: ESRRG
4 Cross references
206 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).